Prokinetic Drugs and Enteral Nutrition
NCT00916591 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2009-06-09
Summary
The purpose of this study is to compare the effect of two drugs that can help in the prevention of regurgitation during the administration of enteral nutrition and define which one is the most effective.
Conditions
- Critically Ill
- Enteral Nutrition
Sponsors & Collaborators
-
Universitair Ziekenhuis Brussel
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
Countries
- Belgium
Study Locations
More Related Trials
-
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
NCT01039805 ·Status: COMPLETED ·Phase: PHASE2
-
Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients
NCT01117376 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
NCT05832151 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
NCT00733551 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways
NCT02633579 ·Status: COMPLETED ·Phase: NA
-
The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms
NCT03810287 ·Status: NO_LONGER_AVAILABLE
-
The Effect of Naloxone and Methylnaltrexone on Esophageal Sensitivity in Health
NCT03014843 ·Status: COMPLETED ·Phase: NA
-
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
NCT00332137 ·Status: COMPLETED ·Phase: PHASE2
-
Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis
NCT01711918 ·Status: COMPLETED ·Phase: NA
-
The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake
NCT02759926 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
NCT06899217 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
NCT06297954 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Atropine Oral Gel
NCT05164367 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
NCT01149369 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy Adults
NCT01347814 ·Status: COMPLETED ·Phase: NA
-
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
NCT00590317 ·Status: COMPLETED ·Phase: PHASE2
-
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
NCT01510379 ·Status: COMPLETED ·Phase: NA
-
The Effect of Motilin on the Frequency and Amount of Food Intake
NCT03024879 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke
NCT04873297 ·Status: COMPLETED ·Phase: PHASE4
-
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NCT06769165 ·Status: RECRUITING ·Phase: NA
-
Codeine on Pharyngeal and Esophageal Motility
NCT03784105 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
NCT04501211 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
NCT04026997 ·Status: TERMINATED ·Phase: PHASE2
-
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
NCT01262898 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Narcotic-Induced Nausea
NCT00541671 ·Status: TERMINATED ·Phase: NA